Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion type Assertion NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_head.
- NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion description "[In the obese-type 2 diabetes scan, FTO variants had the strongest type 2 diabetes effect (rs8050136: relative risk [RR] 1.49 [95% CI 1.34-1.66], P = 1.3 x 10(-13)), with only weak evidence for TCF7L2 (rs7901695 RR 1.21 [1.09-1.35], P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_provenance.
- NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion evidence source_evidence_literature NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_provenance.
- NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion SIO_000772 19056611 NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_provenance.
- NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion wasDerivedFrom befree-2016 NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_provenance.
- NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_assertion wasGeneratedBy ECO_0000203 NP707339.RA6BXoM_9vjjt9G96FrlT1fsdWTtiJuerGgKI-j2f-K5o130_provenance.